发布求助
文献互助 智能选刊 最新文献

Drugs of The Future最新文献

筛选
英文 中文
NME Digest - April 2022 NME文摘- 2022年4月
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.4.3425322
X. Bofill, P. Cole, D. Fernández-Forner
{"title":"NME Digest - April 2022","authors":"X. Bofill, P. Cole, D. Fernández-Forner","doi":"10.1358/dof.2022.47.4.3425322","DOIUrl":"https://doi.org/10.1358/dof.2022.47.4.3425322","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66443668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cefepime/enmetazobactam. Beta-Lactam/beta-lactamase inhibitor, Treatment of complicated urinary tract infection 头孢吡肟/ enmetazobactam。β -内酰胺/ β -内酰胺酶抑制剂，治疗复杂性尿路感染
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.7.3408811
A. Akhir, A. Dasgupta, S. Chopra
{"title":"Cefepime/enmetazobactam. Beta-Lactam/beta-lactamase inhibitor, Treatment of complicated urinary tract infection","authors":"A. Akhir, A. Dasgupta, S. Chopra","doi":"10.1358/dof.2022.47.7.3408811","DOIUrl":"https://doi.org/10.1358/dof.2022.47.7.3408811","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66444759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic targets for dermatomyositis 皮肌炎的治疗靶点
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.9.3461263
L. Sorbera, C. Dulsat, A. Graul
{"title":"Therapeutic targets for dermatomyositis","authors":"L. Sorbera, C. Dulsat, A. Graul","doi":"10.1358/dof.2022.47.9.3461263","DOIUrl":"https://doi.org/10.1358/dof.2022.47.9.3461263","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66446083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent Clinical Disclosures and SMR Award. Highlights from the Society for Medicines Research Conference. Virtual - December 2, 2021 最近的临床披露和SMR奖。来自医学研究学会会议的亮点。虚拟- 2021年12月2日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.8.3447439
M. Swarbrick, M. Hann, D.H. O'Donovan, M. Alavijeh, P. Jeffrey, K. Brown
{"title":"Recent Clinical Disclosures and SMR Award. Highlights from the Society for Medicines Research Conference. Virtual - December 2, 2021","authors":"M. Swarbrick, M. Hann, D.H. O'Donovan, M. Alavijeh, P. Jeffrey, K. Brown","doi":"10.1358/dof.2022.47.8.3447439","DOIUrl":"https://doi.org/10.1358/dof.2022.47.8.3447439","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66445740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
European Federation of Medicinal Chemistry - XXVII International Symposium on Medicinal Chemistry (EFMC-ISMC 2022). Nice - September 4-8, 2022 欧洲药物化学联合会-第二十七届国际药物化学研讨会(EFMC-ISMC 2022)。尼斯——2022年9月4日至8日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.11.3500032
A. Fernández-Llamazares, P. Cole, X. Bofill
{"title":"European Federation of Medicinal Chemistry - XXVII International Symposium on Medicinal Chemistry (EFMC-ISMC 2022). Nice - September 4-8, 2022","authors":"A. Fernández-Llamazares, P. Cole, X. Bofill","doi":"10.1358/dof.2022.47.11.3500032","DOIUrl":"https://doi.org/10.1358/dof.2022.47.11.3500032","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66441679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
European Society of Gene and Cell Therapy (ESGCT) - 28th Annual Meeting. Virtual - October 19-22, 2021 欧洲基因与细胞治疗学会(ESGCT)第28届年会。虚拟- 2021年10月19日至22日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.2.3393245
R. Suria, C. Vergès
{"title":"European Society of Gene and Cell Therapy (ESGCT) - 28th Annual Meeting. Virtual - October 19-22, 2021","authors":"R. Suria, C. Vergès","doi":"10.1358/dof.2022.47.2.3393245","DOIUrl":"https://doi.org/10.1358/dof.2022.47.2.3393245","url":null,"abstract":"The European Society of Gene and Cell Therapy (ESGCT) held its 28th annual congress in virtual format, bringing together experts and product specialists in the field of gene therapy, cell therapy and genetic vaccines.","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66442385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Society for Immunotherapy of Cancer (SITC) - 36th Annual Meeting. Virtual - November 10-14, 2021 癌症免疫治疗学会(SITC)第36届年会。虚拟- 2021年11月10日至14日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.2.3393240
J. Toldrà
{"title":"Society for Immunotherapy of Cancer (SITC) - 36th Annual Meeting. Virtual - November 10-14, 2021","authors":"J. Toldrà","doi":"10.1358/dof.2022.47.2.3393240","DOIUrl":"https://doi.org/10.1358/dof.2022.47.2.3393240","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66442455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Donanemab. Monoclonal antibody targeting N3pG beta-amyloid, Treatment of early Alzheimer's disease Donanemab。靶向N3pG β -淀粉样蛋白的单克隆抗体，治疗早期阿尔茨海默病
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.4.3389009
J. Buxbaum
{"title":"Donanemab. Monoclonal antibody targeting N3pG beta-amyloid, Treatment of early Alzheimer's disease","authors":"J. Buxbaum","doi":"10.1358/dof.2022.47.4.3389009","DOIUrl":"https://doi.org/10.1358/dof.2022.47.4.3389009","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66443553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Taletrectinib adipate. Dual ROS1 and NTRK inhibitor, Treatment of non-small cell lung cancer, Treatment of solid tumors Taletrectinib己二酸。ROS1和NTRK双重抑制剂，治疗非小细胞肺癌，治疗实体瘤
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.7.3413462
Z. Zhang, C. Gao, X. Ma, Z. Li, C. Ashby, L. Wei, Z. Chen
{"title":"Taletrectinib adipate. Dual ROS1 and NTRK inhibitor, Treatment of non-small cell lung cancer, Treatment of solid tumors","authors":"Z. Zhang, C. Gao, X. Ma, Z. Li, C. Ashby, L. Wei, Z. Chen","doi":"10.1358/dof.2022.47.7.3413462","DOIUrl":"https://doi.org/10.1358/dof.2022.47.7.3413462","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66444411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Danuglipron. Glucagon-like peptide 1 receptor agonist, Treatment of type 2 diabetes, Treatment of obesity Danuglipron。胰高血糖素样肽1受体激动剂，治疗2型糖尿病，治疗肥胖
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.6.3373535
A. Sperry, J. Hardy, R. Goldfaden, A. Hurst, A. Ashchi, D. Sutton, M. Sheikh-Ali, J. Huston, R. Choksi
{"title":"Danuglipron. Glucagon-like peptide 1 receptor agonist, Treatment of type 2 diabetes, Treatment of obesity","authors":"A. Sperry, J. Hardy, R. Goldfaden, A. Hurst, A. Ashchi, D. Sutton, M. Sheikh-Ali, J. Huston, R. Choksi","doi":"10.1358/dof.2022.47.6.3373535","DOIUrl":"https://doi.org/10.1358/dof.2022.47.6.3373535","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66444663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信